Moreover, the autologous DCs were pulsed with three distinct HLA-A2-restricted peptides derived from antigens expressed in pancreatic cancer: i) human telomerase reverse transcriptase (hTERT, TERT572Y), ii) carcinoembryonic antigen (CEA; Cap1-6D), and iii) survivin (SRV.A2) [25–27, 30–33]. This evidence concerns the gene CEACAM5 and pancreatic neoplasm.